Valeant is pressing on with its hostile bid for Allergan after a California district court ruled that legal proceedings by Allergan would not be given the go ahead.
Pharmaceutical giant Valeant’s move to create a second-step merger with Botox-maker Allergan has hit hurdles, as Allergan’s CFO resigns at the same time the company is said to be seeking out an alternative buyer.
In an attempt to try and establish a controlling stake in Botox-maker Allergan, Valeant Pharmaceuticals has offered shareholders a combination of cash and Valeant shares.
Having increased its offer to buy out leading personal care
supplier Engelhard, Germany-based BASF is looking more and more
likely to be successful in its hostile takeover bid.
BASF's hostile takeover bid for leading personal care supplier
Engelhard is looking more likely after it was acknowledged that the
Germany-based chemicals giant has been allowed to look at sections
of Engelhard's accounts.
BASF's hostile takeover bid on leading personal care supplier looks
set to be a rocky road, with Engelhard executives warning
stockholders to be cautious over the offer and investors suggesting
that the bid will have to be raised...
Alcan's hostile takeover of French counterpart Pechiney has become
a friendly bid following acceptance of a revised offer for the
company by Pechiney's board. But getting regulatory approval may
prove harder.
